U.S. Bancorp (USB) Upgraded to “Outperform” at CIBC

Share on StockTwits

CIBC upgraded shares of U.S. Bancorp (NYSE:USB) from a market perform rating to an outperform rating in a research note issued to investors on Thursday morning.

A number of other equities analysts also recently weighed in on USB. ValuEngine downgraded U.S. Bancorp from a hold rating to a sell rating in a research note on Monday, July 2nd. Wedbush reiterated a neutral rating on shares of U.S. Bancorp in a research note on Monday, July 23rd. Zacks Investment Research upgraded U.S. Bancorp from a hold rating to a buy rating and set a $61.00 price objective on the stock in a research note on Tuesday, September 18th. Macquarie upgraded U.S. Bancorp from a neutral rating to an outperform rating and upped their price objective for the company from $56.00 to $62.00 in a research note on Wednesday, October 10th. Finally, UBS Group upgraded U.S. Bancorp from a market perform rating to an outperform rating in a research note on Thursday. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and thirteen have issued a buy rating to the company. U.S. Bancorp currently has an average rating of Hold and an average target price of $59.58.

Shares of NYSE USB traded up $0.39 during midday trading on Thursday, reaching $52.52. The company’s stock had a trading volume of 493,396 shares, compared to its average volume of 7,585,397. U.S. Bancorp has a 12-month low of $48.49 and a 12-month high of $58.50. The company has a market capitalization of $86.18 billion, a PE ratio of 15.23, a PEG ratio of 1.73 and a beta of 0.98. The company has a quick ratio of 0.82, a current ratio of 0.85 and a debt-to-equity ratio of 0.91.

U.S. Bancorp (NYSE:USB) last announced its earnings results on Wednesday, October 17th. The financial services provider reported $1.06 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.02. U.S. Bancorp had a return on equity of 15.14% and a net margin of 27.53%. The firm had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.68 billion. During the same quarter in the previous year, the business earned $0.88 EPS. The company’s revenue was up 1.6% compared to the same quarter last year. As a group, research analysts expect that U.S. Bancorp will post 4.08 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, October 15th. Investors of record on Friday, September 28th were paid a $0.37 dividend. This is an increase from U.S. Bancorp’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Thursday, September 27th. This represents a $1.48 annualized dividend and a yield of 2.82%. U.S. Bancorp’s dividend payout ratio is presently 43.27%.

In related news, Vice Chairman John R. Elmore sold 58,924 shares of the company’s stock in a transaction that occurred on Monday, July 23rd. The stock was sold at an average price of $51.71, for a total value of $3,046,960.04. Following the transaction, the insider now owns 98,371 shares in the company, valued at $5,086,764.41. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. 0.43% of the stock is currently owned by corporate insiders.

A number of hedge funds have recently modified their holdings of the business. Massachusetts Financial Services Co. MA raised its holdings in U.S. Bancorp by 0.3% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 41,034,263 shares of the financial services provider’s stock valued at $2,052,534,000 after acquiring an additional 124,650 shares during the period. Bank of New York Mellon Corp increased its holdings in shares of U.S. Bancorp by 15.0% in the second quarter. Bank of New York Mellon Corp now owns 15,867,860 shares of the financial services provider’s stock worth $793,710,000 after purchasing an additional 2,071,326 shares during the period. Janus Henderson Group PLC increased its holdings in shares of U.S. Bancorp by 8.5% in the second quarter. Janus Henderson Group PLC now owns 12,146,468 shares of the financial services provider’s stock worth $607,565,000 after purchasing an additional 946,517 shares during the period. American Century Companies Inc. increased its holdings in shares of U.S. Bancorp by 1.9% in the second quarter. American Century Companies Inc. now owns 10,220,827 shares of the financial services provider’s stock worth $511,246,000 after purchasing an additional 186,828 shares during the period. Finally, Schwab Charles Investment Management Inc. increased its holdings in shares of U.S. Bancorp by 2.3% in the second quarter. Schwab Charles Investment Management Inc. now owns 5,861,928 shares of the financial services provider’s stock worth $293,214,000 after purchasing an additional 132,854 shares during the period. 74.41% of the stock is currently owned by institutional investors and hedge funds.

About U.S. Bancorp

U.S. Bancorp, a financial services holding company, provides various financial services in the United States. The company operates through five segments: Corporate and Commercial Banking, Consumer and Business Banking, Wealth Management and Investment Services, Payment Services, and Treasury and Corporate Support.

Featured Story: Why is insider trading harmful?

Analyst Recommendations for U.S. Bancorp (NYSE:USB)

Receive News & Ratings for U.S. Bancorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Bancorp and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Recent Research Analysts’ Ratings Changes for Hibbett Sports
Recent Research Analysts’ Ratings Changes for Hibbett Sports
Electrovaya  to Release Quarterly Earnings on Wednesday
Electrovaya to Release Quarterly Earnings on Wednesday
Kering  Given a €530.00 Price Target by Goldman Sachs Group Analysts
Kering Given a €530.00 Price Target by Goldman Sachs Group Analysts
Encompass Health  Downgraded to “Hold” at Zacks Investment Research
Encompass Health Downgraded to “Hold” at Zacks Investment Research
Restoration Robotics  Hits New 52-Week Low at $0.98
Restoration Robotics Hits New 52-Week Low at $0.98
Celanese Co.  Stake Lessened by Capital Research Global Investors
Celanese Co. Stake Lessened by Capital Research Global Investors


© 2006-2018 Ticker Report